The thesis

Haleon plc operates in the consumer healthcare sector with a gross margin of 65.57% and a P/E of 18.8x. The company's revenue growth is 1.9% YoY, indicating a stable but slow-growing business. The analyst consensus rating is BUY, but the conviction score is 15/100, suggesting a lack of strong conviction. The high net margin of 14.55% is a positive indicator.

Why now

The expectation of tighter monetary policy for longer, driven by elevated energy prices and bond yields, makes Haleon's defensive positioning in the healthcare sector more attractive. The current macro context, including geopolitical meetings and market reactions, heightens the relevance of Haleon's stable revenue stream.

What to watch

To confirm or deny the thesis, watch Haleon's next quarterly revenue growth report and its ability to maintain current margins. Also, monitor how the market reacts to further tightening of monetary policy and its impact on consumer discretionary spending versus defensive healthcare stocks.

Key risks

The key risks include valuation risk given the current P/E of 18.8x and the risk of slower revenue growth, currently at 1.9% YoY, if consumer spending is curtailed. Execution risk is also present, as Haleon needs to maintain its high gross margin of 65.57% and net margin of 14.55%.

Theme exposure